Augmentin For Suspension
Product Images NDC 71297-240

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Augmentin (NDC 71297-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegis Holdings, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Label 100)

Label (Label 100)
This text appears to be the directions and information for mixing and dosing a medication called AUGMENTIN, which is an oral suspension containing amoxicillin and clavulanate potassium. The text provides step-by-step instructions for mixing the powder with water, dosage information, and storage instructions. It also mentions the need to refrigerate the suspension after reconstitution and to discard it after 10 days. The text includes a National Drug Code (NDC) and the manufacturing information. Please note that the quality is poor and some information may not be accurately extracted.*
FDA Label Image

Label (Label 150)

Label (Label 150)
FDA Label Image

Table (Table 3)

Table (Table 3)
The text provides information about the dosing regimen for Amoxicillin and Clavulanate Potassium, an antibiotic used to treat various infections. The recommended dosing intervals are every 12 hours or every 8 hours, depending on the severity of the infection. The text also mentions different strengths of the oral suspension available, such as 200 mg/28.5 mg per 5 mL, 1400 mg/57 mg per 5 mL, and 1125 mg/31.25 mg per 5 mL, among others. The antibiotic is commonly used for infections such as otitis media, sinusitis, and lower respiratory tract infections. The duration of therapy recommended for acute otitis media is 10 days. Additionally, there is a mention that each strength of the oral suspension is available as a chewable tablet for older children.*
FDA Label Image

Table (Table 6)

Table (Table 6)
FDA Label Image

Table (Table 7)

Table (Table 7)
FDA Label Image

Structure-amoxicillin (Structure Amox 1)

Structure-amoxicillin (Structure Amox 1)
FDA Label Image

Structure-clav-acid (Structure Clav 1)

Structure-clav-acid (Structure Clav 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.